| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2022/10/28 | 05 : 05 | GlobeNewswire Inc. | Prothena to Report Third Quarter 2022 Financial Results on November 3rd | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/09/02 | 05 : 20 | GlobeNewswire Inc. | Prothena to Participate in Upcoming Healthcare Conferences | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/09/02 | 05 : 05 | GlobeNewswire Inc. | Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/08/09 | 05 : 05 | GlobeNewswire Inc. | Prothena Reports Second Quarter 2022 Financial Results and Business Highlights | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/08/03 | 05 : 05 | GlobeNewswire Inc. | Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/08/02 | 05 : 05 | GlobeNewswire Inc. | Prothena to Report Second Quarter 2022 Financial Results on August 8th | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/07/02 | 05 : 16 | GlobeNewswire Inc. | Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/06/03 | 05 : 05 | GlobeNewswire Inc. | Prothena to Participate in Jefferies Healthcare Conference | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/05/06 | 05 : 05 | GlobeNewswire Inc. | Prothena Reports First Quarter 2022 Financial Results and Business Highlights | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/04/29 | 05 : 05 | GlobeNewswire Inc. | Prothena to Report First Quarter 2022 Financial Results on May 5th | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/04/26 | 21 : 30 | GlobeNewswire Inc. | Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/03/28 | 21 : 30 | GlobeNewswire Inc. | Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/03/22 | 05 : 05 | GlobeNewswire Inc. | Prothena to Participate in Stifel 2022 Virtual CNS Days | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/03/16 | 18 : 30 | GlobeNewswire Inc. | Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022 | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/02/18 | 06 : 05 | GlobeNewswire Inc. | Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2022/02/11 | 06 : 05 | GlobeNewswire Inc. | Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022 | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/11/30 | 06 : 05 | GlobeNewswire Inc. | Prothena to Participate in JMP Securities Hematology and Oncology Summit | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/11/05 | 05 : 05 | GlobeNewswire Inc. | Prothena Reports Third Quarter 2021 Financial Results and Business Highlights | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/10/29 | 05 : 05 | GlobeNewswire Inc. | Prothena to Report Third Quarter 2021 Financial Results on November 4th | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/10/02 | 05 : 30 | GlobeNewswire Inc. | Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/10/02 | 05 : 05 | GlobeNewswire Inc. | Prothena Announces Executive Appointments | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/09/04 | 05 : 05 | GlobeNewswire Inc. | Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/09/02 | 05 : 05 | GlobeNewswire Inc. | Prothena to Participate in Upcoming September Healthcare Conferences | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/08/06 | 05 : 05 | GlobeNewswire Inc. | Prothena Reports Second Quarter 2021 Financial Results and Business Highlights | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/07/30 | 05 : 05 | GlobeNewswire Inc. | Prothena to Report Second Quarter 2021 Financial Results on August 5th | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/07/26 | 22 : 00 | GlobeNewswire Inc. | Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021 | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/07/21 | 05 : 05 | GlobeNewswire Inc. | Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Confer... | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/07/12 | 20 : 00 | GlobeNewswire Inc. | Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/06/24 | 21 : 30 | GlobeNewswire Inc. | Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and ... | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
| 2021/06/11 | 03 : 18 | GlobeNewswire Inc. | Prothena to Participate in JMP Securities Life Sciences Conference on June 16 | NASDAQ:PRTAV | Prothena Corp. Plc - Ordinary Shares (MM) |
